SOURCE: Press Ventures

October 11, 2013 17:00 ET

Press Ventures Launches Online Engineering Application for CLO-D Biosafety System Sales and Marketing

WARSAW, POLAND--(Marketwired - Oct 11, 2013) - Press Ventures Inc. (OTCQB: PVEN) ("Press Ventures" or the "Company"), through its wholly-owned Polish subsidiary Biosafety Systems, Inc. Sp z o.o. ("BSI"), is pleased to announce that it has launched an online systems engineering application for its patented natural Cedar Leaf Oil Diffusion ("CLO-D") bacteria and virus biosafety system on the BSI website.

The newly designed online engineering application highlights and details the CLO-D biosafety system's features, advantages, and benefits which enables consumers to select which of the pre-engineered or custom configurations will best meet their unique biosafety requirements.

"The new CLO-D e-commerce app will also enable our trained product sales and marketing specialists to fully engage with prospective buyers and industry professionals to refine and fulfill individual user needs and requirements," stated Mr. Edward Denkiewicz, Press Ventures CEO. "All of this has been carefully orchestrated to enable BSI to rapidly bring our products to market and realize revenue generation accordingly."

About Press Ventures

Press Ventures holds the worldwide rights to the patented Cedar Leaf Oil Diffusion ("CLO-D") technology for the use of natural products to kill bacteria, mold, and viruses in buildings. The patented CLO-D technology has been shown to be capable of killing many deadly bacterial and viral substances such as anthrax and H1N1 in buildings while they are still occupied. The CLO-D technology has been laboratory and field tested and the Company believes that use of the technology can provide a marked improvement in air quality and eliminate many of the most dangerous airborne bacteria, viruses, and pollutants. For additional information about CLO-D technology and Press Ventures, please visit

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, potential revenue generated by CLO-D product sales, and capability of the Company's technology and market information. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products or technologies and operating as a development stage company, our ability to retain important members of our management team and attract other qualified personnel, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, our ability to develop and commercialize products based on our technology platform, and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at

Contact Information